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Protein delivery to restricted plasma membrane domains is exquis-
itely regulated at different stages of the cell trafficking machinery.
Traffic control involves the recognition of exportretention
retrieval signals in the endoplasmic reticulum (ER)Golgi complex
that will determine protein fate. A splice variant (SV), SV1, of the
voltage- and Ca2-activated K channel -subunit accumulates the
channel in the ER, preventing its surface expression. We show that
SV1 insert contains a nonbasic, hydrophobic retentionretrieval
motif, CVLF, that does not interfere with proper folding and
tetramerization of SV1. Localization of proteins in the ER by CVLF
is independent of its position; originally, on the first internal loop,
SV1 insert or CVLF perform equally well if placed at the middle or
end of the -subunit intracellular carboxyl terminus. Also, CVLF is
able to restrict the traffic of an independently expressed trans-
membrane protein, 1-subunit. CVLF is present in proteins across
species and in lower organisms. Thus, CVLF may have evolved to
serve as a regulator of cellular traffic.
Large-conductance, voltage- and Ca2-activated K (MaxiK)channels are ubiquitously expressed, except in heart myocytes,
and play important roles in regulating cell excitability including
neurotransmission and smooth muscle tone. They are composed of
the pore-forming - and modulatory -subunits (1, 2). The human
MaxiK -subunit (hSlo) is the product of a single gene with many
possibilities for splice variation, which predicts the existence of
multiple isoforms of the same channel with potentially diverse
functions (3). Four modulatory -subunit genes add to this diversity
(2). Accordingly, MaxiK (or BK) channels have different electrical
properties and levels of expression from tissue to tissue and within
tissues (4, 5). In addition, their numbers in the plasma membrane
can decrease under different physiological conditions such as
pregnancy term (6) and coronary aging (7), resulting in higher
muscle contractility.
Normal cell performance requires a delicate control of protein
expression at the correct time and place. There are multiple
mechanisms that regulate membrane protein localization and
include those regulating transcription, protein synthesis, traffic,
and targeting to specific regions or microdomains at the cell
surface. Protein traffic is governed by the molecular recognition
of signals, short stretches of amino acids embedded at various
positions within proteins, at different stages of the secretory
pathway beginning in the endoplasmic reticulum (ER). Traffic
through the ER involves: (i) retention signals that inhibit forward
movement of the protein, (ii) retrieval signals that return the
escaped proteins to the initial resident compartment, and (iii)
export signals that expedite protein exit from the ER organelle
(8, 9). Retentionretrieval sequences have been identified for
many luminal and monotopic (type I) transmembrane proteins,
consisting mainly of carboxyl-terminal KDEL, RRXX, and
KKXX motifs (8). However, just a handful of polytopic protein
(type III transmembrane proteins) retentionretrieval sequences
have been identified. These sequences consist of basic motifs
(RXR, KR, RRKK, and RR) located in cytosolic regions of ion
channels (KATP, KCNK, glutamate-gatedNMDA, and Kainate)
(10–12) and of metabotropic glutamate receptor 1B (13), al-
though a transmembrane motif (PLYFXXN) in acetylcholine
receptor 1-subunit keeps unassembled subunits in the ER (14).
The amount of protein expressed on the cell membrane will
depend, at the ER level, on an exquisite balance of protein export
and retention mechanisms. The effectiveness of protein export is
regulated not only by proper folding and assembly but also by
forward signals (15, 16). In addition, export will occur if retention
retrieval signals are masked by association with subunits (10) or by
SVs (12, 13, 17). We recently identified an SV, SV1, that localizes
hSlo within the ER (18). SV1 contains a 33-aa insert after leucine-
115 in the S1 transmembrane domain. The SV insert does not
modify the hydrophobicity plot of S1 but instead replaces few
hydrophobic amino acids and makes the S0–S1 intracellular linker
longer. The hydrophobicity plot predicts that 27 aa are likely in the
cytoplasmic linker of transmembrane segments S0 and S1 and that
6 aa are buried in transmembrane segment S1 (Fig. 1, shadowed
amino acids) (18). However, homology analysis shows that none of
the known ER retention motifs are present in the insert. We now
report a hydrophobic ER retentionretrieval motif, CVLF, which
inhibits the surface expression of the SV1 of MaxiK -subunit. The
same motif is present in other membrane proteins and inhibits the
surface expression of an independently expressed 1-subunit, sug-
gesting the easy access of this sequence to the cellular trafficking
machinery and its potential role as a common ER retention
retrieval sequence.
Methods
Constructs and Transfection. hSlo (U11058) and SV1 have an
extracellular amino-terminal c-Myc epitope (18, 19). SV1-Middle
and SV1-END contain the SV1 33-aa insert in the middle (between
K588 and I589 with downstream L-K junctional amino acids) or the
end of hSlo carboxyl terminus (Fig. 1). Human 1 (U25138)
contains CVLF (1CVLF) or QKDG (1QKDG) followed by
a c-Myc epitope at the intracellular carboxyl terminus. HEK293T
cells were transfected with constructs in pcDNA3 and used after
3–4 days (18, 19). The day before immunocytochemistry, cells were
transferred to chamber slides precoated with 0.1 mgml poly(D-
lysine) and 0.1 mgml collagen.
Abs. Affinity-purified polyclonal Abs against hSlo (1–1.2 gml
anti-hSlo883–896, Alomone Labs, Jerusalem) (6, 20) and ERp72
(1 gml, Calbiochem) (21, 22), polyclonal 1 Ab (11,000 anti-
185–102) (23), and anti-c-Myc monoclonal Ab (2 gml clone 9E10)
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were used. In all experiments, a negative control was transfection
with no DNA. Ab specificity was tested by preadsorbing each Ab
with the corresponding antigenic peptide.
Nonpermeabilized and Permeabilized Labeling. Live cells were
treated for 1 h (4°C) with Abs against extracellular epitopes of hSlo
(anti-c-Myc) or 1 (anti-185–102) constructs. Cells were fixed with
4% paraformaldehyde before permeabilization with 0.2% Triton
X-100 and double labeling; incubation with primary Abs was
overnight at 4°C. For hSlo constructs prelabeled with anti-c-Myc
(nonpermeabilized), anti-hSlo883–896 was used. Cells were incu-
bated for 1 h with biotinylated anti-mouse Ab, washed, and
incubated for 1 h with 1 gml fluorescein-avidin (Vector Labo-
ratories) and 7.5 gml Rhodamine Red-X-conjugated donkey
anti-rabbit Ab (Jackson ImmunoResearch). For 1 constructs
prelabeled with anti-185–102 (nonpermeabilized), anti-c-Myc was
used. Cells were washed and incubated with 6 gml FITC-
conjugated donkey anti-rabbit (Jackson ImmunoResearch) and 6
gml Rhodamine Red-X-conjugated donkey anti-mouse Abs.
Colabeling of Erp72 and hSlo was under permeabilized conditions
with anti-c-Myc, anti-Erp72623–638, 6.5 gml FITC-conjugated
donkey anti-mouse, and Rhodamine Red-X-conjugated donkey
anti-rabbit Abs. Cells were mounted by using ProLong (Molecular
Probes).
Cell Surface Biotinylation and Immunoprecipitation (IP). Live cells
were incubated for 1 h with 0.08 mgml EZ-Link Sulfo-NHS-
LC-Biotin (Pierce) at 4°C. After washing, half of the cells were
used for immunocytochemistry to check that only surface pro-
teins were biotinylated, and half were used for IP. For IP, cells
were lysed in 50 mM Tris, 150 mM NaCl, 1% Nonidet P-40, 0.5%
sodium deoxycholate, and protease inhibitors (pH 8.0) and
centrifuged for 15 min at 15,000  g (24). Solubilized proteins (3
mgml) were immunoprecipitated with antibiotin beads. Beads
were washed extensively and resuspended in SDS loading buffer
before 7.5% SDSPAGE and immunoblotting. Signals were
analyzed as described in ref. 6
Soluble and Insoluble Fractions. Cells (2  105 per 100 l) were
solubilized in Tris-buffered saline (pH 8) containing 5 mM EDTA,
1 mM iodoacetamide, protease inhibitors, and 0%, 0.1%, or 1%
Triton X-100. After 10 min on ice, lysates were centrifuged for 5 min
(15,000  g at 4°C). Solubilized fractions were saved, and insoluble
fractions were washed and resuspended in equal volume as the
soluble fractions (100 l). Samples were boiled in SDS loading
buffer with 1.4 M 2-mercaptoethanol, and 10 l was fractionated
on 7.5% SDSPAGE and immunoblotted.
Nonreducing Versus Reducing Conditions. Cells were solubilized in
150 mM NaCl, 20 mM Hepes, 5 mM EDTA, and 1% CHAPS (pH
7.4) with protease inhibitors, and centrifuged at 15,000  g for 10
min at 4°C. Solubilized fractions were precleared for 1 h with
protein A-Sepharose beads and centrifuged at 100,000  g for 30
min at 4°C. Soluble proteins (10 g) were mixed with SDS loading
buffer with or without 1.4 M 2-mercaptoethanol, run on 7.5%
SDSPAGE, and immunoblotted.
Sucrose Gradient. Cell lysates (150 g of protein) or 150 g of
protein markers (Apoferritin, 440 kDa; -amylase, 200 kDa; and
alcohol dehydrogenase, 150 kDa) were layered on top of 5–50%
continuous sucrose gradient prepared in 150 mM NaCl, 20 mM
Hepes, 5 mM EDTA, and 1% CHAPS (pH 7.4) containing
protease inhibitors. Samples were centrifuged for 18 h at 182,298 
g in a swinging rotor; 10 aliquots (400 l each) were collected from
the top of each gradient. Proteins of each fraction were concen-
trated by using PAGEprep protein clean-up resin (Pierce), reduced
by 0.7 M 2-mercaptoethanol, boiled for 5 min, fractionated on 7.5%
SDSPAGE, and immunoblotted. Signals were detected by using
infrared fluorescence (Li-Cor, Lincoln, NE).
Image Analysis and Statistics. Confocal sections were acquired every
0.25 or 0.5 m and, unless otherwise stated, analyzed with IMAGE-
PRO PLUS (Media Cybernetics, Silver Spring, MD) or IMAGEJ
(National Institutes of Health). Total protein expression was the
mean intensity of cell outlines labeled under permeabilized condi-
tions; surface expression was measured by using the same outlines
superimposed on the same section labeled under nonpermeabilized
conditions. All conditions including optical sectioning, number of
sections, and exposures were identical for a given experiment.
Fig. 1. The retention capacity of the
SV1 insert is prominently independent
of its location. (A–D) hSlo constructs (c-
Myc epitope, triangle) and correspond-
ing expression patterns in nonperme-
abilized and permeabilized conditions.
Shown are the SV1 insert (gray box
dashed line) (A–C) and partial sequence
at its carboxyl terminus (A). In SV1 (wild
type) (A), CVLF (boxed) lies in the S0-S1
linker. SV1 (A), SV1-Middle (B), or SV1-
END (C) showed no or insignificant sur-
face labeling (nonpermeabilized) but
were efficiently synthesized (perme-
abilized). (D) Insertless hSlo (control)
with clear surface expression (nonper-
meabilized). (E) Percent intensity with
respect to hSlo. The number of cells are:
27 (bars A), 32 (bars B), 51 (bars C), and
77 (bars D). (F) DIC (Left) and biotin
labeling (Center) (Texas Red avidin,
Vector Laboratories) of surface proteins
(arrowhead) in living cells; intracellular
milieu free of biotin labeling (arrow).
Right shows overlap (arrowhead, sur-
face proteins; arrow, no intracellular
labeling). (G) Immunoblots with anti-hSlo883– 896 of IP surface proteins (lanes 1–3) and of cell lysates (lanes 4 – 6). hSlo molecular mass is 125 kDa. (H) Percent
blot intensities normalized to corresponding hSlo values. n  3. In this and following figures, pictures are single confocal sections taken at the middle of
cells. (Bars  10 m.)








Values are means  SE. Student’s t test at P  0.05 was considered
significant.
Results
The Retention Capacity of the SV1 Insert Is Prominently Independent
of Its Location. To determine whether SV1 insert has a potential
retentionretrieval motif contained within its sequence, we first
tested whether its retention ability was position-dependent. We
created constructs with the 33-aa insert in three different
locations within hSlo (Fig. 1 A–D). Cells that were transfected
with the naturally occurring SV1 (18) showed no surface labeling
(A, nonpermeabilized), whereas significant labeling was de-
tected after permeabilization (Fig. 1 A, permeabilized). Similar
results were observed when SV1 insert was relocated to the
middle (B) or the end (C) of hSlo carboxyl terminus. As a
control, cells transfected with insertless hSlo show prominent
surface expression (Fig. 1D, nonpermeabilized).
Quantification of the labeling intensities (Fig. 1E) showed that
SV1 (A), SV1-Middle (B), and SV1-END (C) have strikingly lower
(21%) surface expression than hSlo (D) (nonpermeabilized),
whereas no significant differences were observed in their total
protein expression (permeabilized). SV1-Middle (Fig. 1B) and
SV1-END (C) showed slightly higher surface expression when
compared with SV1 (A) (nonpermeabilized). This slight increase in
surface expression may be due to changes in accessibility of the SV1
retention signal to its receptor. Despite this modest escape observed
when SV1 insert is outside of its native position, these results
indicate that the retention capacity of the SV1 insert is largely
independent of its location and, thus, could contain a retention
retrieval motif.
To verify our results with an alternative method, we used a
biotinylation approach to measure surface protein expression. Fig.
1F displays an example of cells transfected with SV1-Middle that
were biotinylated and fluorescently labeled. Single confocal images
at the middle of the cells show that only surface proteins were
biotinylated (labeling is restricted to the periphery of the cells;
arrowheads) with no intracellular labeling (arrows) (see also over-
lap). Fig. 1G shows a Western blot of surface (IP, lanes 1–3) and
total (lysate, lanes 4–6) protein obtained from cells expressing hSlo,
SV1-Middle-transfected cells, and nontransfected cells (control,
lanes 3 and 6). Consistent with optical experiments, SV1-Middle
(lane 2) showed significantly lower surface expression than hSlo
(lane 1), inasmuch as both had similar total protein (lanes 4 and 5).
Quantification (Fig. 1H) shows that SV1-Middle surface expression
(IP) is minimal (5%) when compared with hSlo.
SV1 Insert Outside Its Natural Environment also Localizes hSlo Protein
Within the ER. We reasoned that if SV1 contains an ER retention
retrieval signal, the constructs SV1-Middle and SV1-END should
also localize the protein in the ER. To test this hypothesis, cells
expressing SV1-Middle and SV1-END were double-labeled with
anti-c-Myc and anti-ERp72 (ER marker) Abs under permeabilized
conditions. Fig. 2A shows that SV1-Middle displays a network
pattern (square) that strongly mimics ER expression. The overlap
and higher magnification (Fig. 2B) display the striking similarity
between the two expression patterns. Similarly, SV1-END (Fig. 2C)
shows a strong colocalization with the ER marker. For comparison,
cells were transfected with insertless hSlo and double-labeled under
identical conditions (Fig. 2D). Consistent with normal protein
trafficking, a significant amount of hSlo is localized within the ER
(arrowheads), but, in this case, the synthesized hSlo can reach its
destination on the cell surface (arrows). These experiments are a
strong indication that the SV1 insert is sufficient to strongly
promote the localization of the protein in the ER where the
prototype ERp72 protein resides.
Identification of a Hydrophobic RetentionRetrieval Motif, CVLF, in
SV1. To determine which amino acids of the SV1 insert (Fig. 3,
sequence at top) are responsible for hSlo localization in the ER, we
first made serial carboxyl-terminal deletions of the SV1-END
construct (Fig. 3 A and F). Deletion of the last 8 aa (HFMPRLLM)
caused a slight increase (20%) (Fig. 3E) in surface expression
when compared with the whole insert (Fig. 3 B vs. A, nonperme-
abilized). This result might indicate that the molecular environment
provided by the spatial arrangement of these amino acids may
facilitate, but is not critical for, full protein retention. In contrast,
deletion of the next 8 aa (CQCVLFSS) induced a loss of the
retention capability of the insert, allowing a drastic increase in
surface expression (Fig. 3C, nonpermeabilized) similar to the WT
channel (Fig. 3D).
Quantification of labeling intensities (Fig. 3E) shows that, al-
though all constructs had similar total protein expression (red bars),
their surface expression (green bars) clearly depended on the insert
segment that they contained. Constructs containing the CQCV-
LFSS sequence showed 40% surface expression (Fig. 3E, green
bars A and B), whereas the construct lacking this sequence lost its
ability to retain the protein showing nearly 100% surface expression
(green bar C) (similar to levels achieved by the insertless hSlo; green
bar D). These results strongly indicated that the motif causing
localization of hSlo in the ER was contained within the CQCV-
LFSS epitope.
To test the hypothesis that CQCVLFSS contains a short string of
amino acids responsible for the SV1 retention in the ER, we
replaced the whole SV1-Middle insert (Fig. 4 A and I) with the
CQCVLFSS sequence alone (Fig. 4 B and I). To further circum-
scribe the potential retentionretrieval motif, we simultaneously
mutated two or four residues to alanines (Fig. 4 C–F) because
retentionretrieval motifs are usually a string of two to four
Fig. 2. SV1 insert-containing constructs are predominantly retained within
the ER. Cells expressing SV1-Middle, SV1-END, or hSlo were double-labeled
with anti-c-Myc (green) and anti-ERp72 (red) under permeabilized conditions.
(A) SV1-Middle had a network expression pattern (square) strongly mimicking
the ER. Overlap illustrates a striking colocalization (yellow). (B) Higher mag-
nification (squares in A). (C) SV1-END also shows strong colocalization with the
ER marker. (D) hSlo shows ER colocalization (arrowheads) and significant
expression at the periphery (arrows). Images were 3D subpixel deconvolved by
using AUTOQUANT (representative of 15 cells; n  3 experiments).
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residues. Control experiments included (i) a construct containing
the upstream sequence RISIQKDG (Fig. 4G), which should not
retain protein in the ER as suggested by the serial deletion
experiments (Fig. 3C), and (ii) parallel transfections with SV1-
Middle (Fig. 4A). As predicted, the RISIQKDG epitope showed no
ER retentionretrieval properties because the protein freely
reached the surface (Fig. 4G). In contrast, when cells were trans-
fected with CQCVLFSS (Fig. 4B), hSlo protein was practically
absent from the surface, indicating that this fragment is sufficient
to produce full retention.
Results are quantified in Fig. 4H as a percentage of RISIQKDG
expression. None of the constructs significantly affected total cell
expression (permeabilized, red bars). Similar to SV1-Middle,
CQCVLFSS showed 10% surface labeling (Fig. 4H, bars A and
B, nonpermeabilized), whereas all alanine mutants tested (bars
C–F) displayed 50% loss of the CQCVLFSS epitope’s retention
ability. Notice that alanine mutants had in common the substitution
of either CV or LF by alanines, implicating the hydrophobic CVLF
motif as the trafficking signal responsible for hSlo localization in
the ER.
The CVLF Motif Is a Trafficking Signal That Inhibits Surface Expression
of Polytopic Proteins. ER retentionretrieval sequences of mono-
topic and polytopic proteins are commonly formed by basic amino
acids. Thus, it was remarkable to find that the motif of SV1
responsible for hSlo confinement in the ER could be a hydrophobic
motif, CVLF. The CVLF hydrophobic motif is not predicted to
form part of a transmembrane domain, but rather it would be
located near the membrane facing the cytoplasm (Fig. 1A).
To assess the retentionretrieval nature of CVLF motif, we
performed two tests: locate the CVLF motif at the middle of the
carboxyl terminus of hSlo, away from its natural environment (Fig.
5A), and attach CVLF to the carboxyl terminus of an independently
expressed transmembrane protein, the 1-subunit (Fig. 5D) (18).
Immunolabeling experiments clearly demonstrate that CVLF can
indeed act by itself as a retentionretrieval motif because no
significant surface labeling was observed regardless of the back-
ground protein. Fig. 5B shows the tremendous reduction in hSlo
surface expression (nonpermeabilized) by CVLF and its effective
confinement in the intracellular compartment (permeabilized). As
a control, we used hSloRISIQKDG, which does not have the
ability to restrain the protein in the ER (Figs. 4G and 5C).
The same pattern was observed when the 1-subunit containing
CVLF was used (Fig. 5D). Striking is the reduction in surface
protein expression of 1CVLF and its intracellular localization
(Fig. 5E, nonpermeabilized vs. permeabilized). The control 1
protein contained QKDG (Fig. 5F), a string of amino acids in SV1
that does not cause retention (Figs. 3C and 4G), instead of CVLF.
As illustrated in Fig. 5F, QKDG allowed the 1-subunit to readily
reach the membrane (nonpermeabilized). Quantification shows
that total expression was not modified in any of the constructs (Fig.
5G, permeabilized) and that the CVLF motif had the ability to
restrain nearly 90% of the proteins in the ER. This level of
effectiveness was similar to the one attained when the whole SV1
insert was located in the same position in hSlo (Fig. 1).
The CVLF Motif Does Not Interfere with Proper Folding and Tetramer-
ization of the MaxiK Constructs. We used biochemical approaches to
determine whether protein misfolding was responsible for the ER
retention of the SV1 and hSloCVLF constructs. To assess folding
Fig. 3. Serial carboxyl-terminal deletions demonstrate that the majority of the
SV1retentioncapacity is confinedto8aaof theSV1 insert. (A–D) Transfectedcells
labeled under nonpermeabilized (green) and permeabilized (red) conditions. (A)
Full-length SV1-END served as reference of ER localization; amino acids were
color-coded according to their location in the sequence shown at the top. Almost
all protein is localized in the ER (permeabilized) with minimal surface expression
(nonpermeabilized). (B) Removal of the last 8 aa (green bar) caused a slight
increase in surface labeling (nonpermeabilized). (C) Deletion of the next 8 aa (red
bar) significantly relieved retention (strong surface labeling, nonpermeabilized).
(D) hSlo, control for unrestricted surface expression. (E) Percent intensities nor-
malized to hSlo expression. Number of cells are as follows for four experiments:
51 (bars A), 45 (bars B), 43 (bars C), 54 (bars D). (F) SV1-end model.
Fig. 4. Site-directed mutagenesis demon-
strates that mutations within CQCVLFSS signif-
icantly relieve retention. (A) SV1-Middle as ref-
erence of SV1 retentionretrieval ability. Color
code is the same as in Fig. 3. (B) CQCVLFSS
insert (red box in model) localizes the protein
in the intracellular compartment. (C–F) Ala-
nine substitutions in the CQCVLFSS fragment
relieved retention (nonpermeabilized). (G)
Upstream RISIQKDG at same position as
CQCVLFSS has unrestricted surface expression
(control). (H) Percent intensity under nonper-
meabilized and permeabilized conditions nor-
malized to control values (G). Number of cells
are as follows from three experiments: 45 (bars
A), 49 (bars B), 45 (bars C), 47 (bars D), 57 (bars
E), 49 (bars F) and 54 (bars G). (I) Models. (Bar 
20 m.)








integrity, hSlo-, SV1-, and hSloCVLF-expressing cells were an-
alyzed for solubility in buffers containing different concentrations
of the nonionic detergent Triton X-100. Insolubility in nonionic
detergent is a useful indicator of gross misfolding of membrane
proteins (25, 26). We found that, like hSlo, SV1 and hSloCVLF
were soluble even at 0.1% Triton X-100 (Fig. 6A), consistent with
properly folded SV1 and hSloCVLF membrane proteins.
Alternatively, CVLF motif may prevent assembly and tetramer-
ization of the MaxiK channels. Unassembled membrane proteins
would then be retained in the ER and degraded by quality-control
mechanisms. To determine whether retention of CVLF-containing
constructs in the ER was due to defects in tetramerization, hSlo-,
SV1-, and hSloCVLF-expressing cells were solubilized and im-
munoblotted under nonreducing and reducing conditions (Fig. 6B).
Our results illustrate the existence of monomers, dimers, trimers,
and tetramers for hSlo, SV1, and hSloCVLF under nonreducing
conditions and monomers under reducing conditions. Compelling
evidence for normal tetramerization was obtained by sucrose-
density gradient (Fig. 6C), showing that the majority of hSlo, SV1,
and hSloCVLF proteins appear in the fractions similar to apo-
ferritin, which has a molecular mass (440 kDa) close to the
estimated molecular mass of hSlo tetramers (500 kDa). From
these findings, we can conclude that CVLF-containing constructs
are folded properly and can form tetramers.
In summary, a retentionretrieval motif, CVLF, has been dis-
covered that is unique in its lack of basic amino acids and in its
hydrophobic nature.
Discussion
Previously, we isolated a Slo SV, SV1, that contains a 33-aa insert
in S1 transmembrane domain and showed that SV1 is retained
within the ER organelle acting as a dominant-negative modu-
lator of hSlo surface expression (18). In this study, we found that
the SV1 insert retentionretrieval property is not exclusive to its
native position in hSlo or to hSlo protein but rather contains an
ER retentionretrieval motif, CVLF. The CVLF hydrophobic
motif is sufficient to prevent surface expression of independently
expressed membrane proteins by trapping them in the intra-
cellular compartments, likely the ER. In addition, CVLF-
containing channels are tetramerized and have similar solubility
to WT hSlo. These results suggest that retention by CVLF motif
may be receptor-mediated.
Trafficking Signals Vary in Their Location and Composition. Traffick-
ing signals of few polytopic proteins have been identified. The
emerging picture is that the majority contain basic (RXR, KR,
RRKK, and RR) retentionretrieval intracellular motifs (10–13).
However, recent studies of the acetylcholine receptor indicate that
an amphipatic ER retentionretrieval motif that lacks basic residues
(PLYFxxN) may be located in the transmembrane region of the
receptor (14). Also, a transmembrane segment of the ryanodine
receptor Ca2 channel seems to contain a sequence for ER
localization; however, its molecular identity is not known yet (27).
Further evidence suggesting the multiplicity of retentionretrieval
sequences comes from studies using monotopic proteins (type I
transmembrane proteins), such as the cytochrome P450 2C1 that
contains a relatively sequence-independent retrieval transmem-
brane signal (28). The CVLF cytosolic motif reported here has two
distinguishing characteristics: its lack of basic amino acids and its
hydrophobic nature. Kyte–Doolittle hydrophobicity analysis (29)
indicates that CVLF motif could be adjacent to the plasma mem-
brane linked by four amino acids (SSHF) to the S1 transmembrane
domain of MaxiK channels (Fig. 1A). Thus, it appears that reten-
tionretrieval motifs of transmembrane proteins have evolved to a
variety of retentionretrieval signals that are not always soluble
linear motifs but may be more complex signals to assure the
physiologically needed expression level in the plasma membrane.
The CVLF Motif Is Present in Proteins Across Species. The CVLF motif
may be a common retrievalretention signal as demonstrated by its
Fig. 5. Hydrophobic CVLF motif is sufficient to inhibit surface expression of
polytopic proteins, hSlo, and 1-subunit. (A) CVLF (box) position is the same as
constructs in Fig. 4. hSloCVLF shows practically no surface labeling (nonper-
meabilized) and retains protein intracellularly (permeabilized). (C) Substitut-
ing CVLF with RISIQKDG (control) at the same position shows strong surface
labeling (nonpermeabilized). (D) 1-subunit with CVLF (box) and c-Myc
epitope (triangle). (E) CVLF inhibited 1-subunit surface labeling (nonperme-
abilized) and localized it intracellularly (permeabilized). (F) Substituting CVLF
with the QKDG sequence (control) allowed protein surface expression (non-
permeabilized). (G) Percent intensity measurements were normalized to con-
trol constructs. Number of cells in three experiments are as follows: 38
(hSloCVLF), 52 (1CVLF), 42 (hSloRISIQKDG, hSlo control), and 69
(1QKDG, 1 control). (Bars  20 m.)
Fig. 6. The CVLF motif does not interfere with folding and tetramerization
of channels. (A) Immunoblot of hSlo, SV1, hSloCVLF, and control (untrans-
fected) cell lysates in 0%, 0.1%, and 1% Triton X-100. S, Solubilized fraction;
P, nonsolubilized fraction (n  2). (B) Immunoblots of hSlo, SV1, and
hSloCVLF in nonreducing and reducing conditions. Dots mark expected sizes
for tetramers, trimers, dimers, and monomers (n  4). Parallel immunocyto-
chemistry experiments of the samples in A and B showed the usual ER-
retention properties of CVLF-containing constructs. (C) Immunoblot (Upper)
and Coomasie blue gel (Lower) after nonreducing continuous sucrose gradi-
ent sedimentation. Plot shows hSlo, SV1, and hSloCVLF migration pattern
similar to apoferritin (n  2).
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ability to localize to the ER an independently expressed protein, the
transmembrane 1-subunit of the MaxiK channel (Fig. 5). In fact,
a database search revealed that the CVLF motif is found in proteins
across species and in lower organisms such as bacteria and yeast.
Moreover, CVLF motif is present in mammalian (human, pig, and
mouse; P55072, P03974, and Q01853, respectively) amphibian
(Xenopus laevis, P23787), and nematode (Caenorhabditis elegans,
P54811) homologs of transitional ER ATPase, p97, a cytosolic
protein bound to ER membranes that transports proteins from the
ER into the cytosol (30) and is also involved in ER assembly (31).
This evidence supports the view that CVLF may be another
prototypical ER retentionretrieval motif distinct from the classical
basic motifs, and suggests that CVLF may have ancient origins
being selected through evolution.
In humans, 23 unrelated proteins were found that contain CVLF
motif at different positions. Among them are GTP-binding proteins
Rab8 (NP005361) and Rab10 (NP057215). Both Rab8 and Rab10
contain the CVLF motif and have 66% identity. Despite the high
degree of homology between Rab8 and Rab10, the two proteins are
localized to distinct cellular compartments. Whereas Rab8 is lo-
calized to the cell periphery, Rab10 is expressed in the perinuclear
region (32). The cell periphery localization of Rab8 may be due to
its ability to mask the CVLF motif. In this view, CVLF may behave
similarly to the RKR motif of KATP channels (10) and the I–II loop
of the Ca2 channels (33). In KATP and Ca2 channels, the masking
of the ER retention signals is a prerequisite for surface expression.
We attempted to mask CVLF by coexpression of the SV1 with hSlo
(insertless) or 1 (18). These subunits were unable to mask the
CVLF motif in the SV1. Further study could be directed to identify
proteins that may release the SV1 from the ER.
Potential Mechanism of Retention and Quality Control by CVLF Motif.
Different mechanisms could ensure the ER localization of CVLF-
containing proteins like SV1: (i) CVLF may induce misfolding of
the proteins that may lead to ER retention through aggregation or
interaction with ER chaperones (8), (ii) CVLF may retain channels
in the ER by inhibiting their tetramerization similar to KATP
channels (10), or (iii) CVLF may act as retention andor retrieval
signal. Our results effectively exclude the first two mechanisms by
illustrating that CVLF-containing channels are folded properly, can
form tetramers (Fig. 6), and support retention andor retrieval as
mechanisms that can explain ER retention by CVLF. Further study
is needed to investigate which mechanisms and receptors are
responsible for the ER localization of CVLF-containing proteins.
Because of the hydrophobic nature of CVLF, the mechanism
involved in localizing proteins to the ER may include the recogni-
tion of a lipid environment. This mechanism could be rather
important for proteins containing the CVLF motif in a transmem-
brane region. Supporting this view, lipid composition has been
shown to be important in ER transport mediated by coatomer
protein II that drives anterograde transport from the ER to the
Golgi system (34).
Retentionretrieval signals of plasma membrane proteins can be
a quality-control checkpoint for correct oligomeric assembly. This
quality check mechanism is used by the KATP channel, whose basic
retentionretrieval signals present in both - and -subunits are
masked only when the channel is correctly coassembled into an
octamer (10). Another example is the nicotinic acetylcholine
receptor, whose ER retentionretrieval signal located in transmem-
brane domain 1 is buried in correctly assembled acetylcholine
receptor pentamers. In this way, only correctly assembled proteins
will be able to reach the plasma membrane, whereas unassembled
subunits with exposed retentionretrieval signals would be confined
to the ER. Retentionretrieval signals can also be a mechanism of
modulating the expression levels of membrane proteins (18). Mod-
ulation of expression could also be achieved by changing the
potency of trafficking signals. Interestingly, conserved substitutions
to the CVLF motif to CILF can also be found in the database. A
combinatorial analysis of arginine- and lysine-based hypothetical
ER localization signals indicates that changes in local sequence
context may give rise to a variety of signal strengths (35). In fact,
when the SV1 insert or the CVLF motif is changed from its natural
molecular environment, the strength of the retention signal is
diminished by 5–20% (Figs. 1 and 4).
The MaxiK channel functions in different tissues can be influ-
enced by their expression levels. How cells achieve a correct number
of channels on the cell surface is poorly understood. Recently, we
introduced down-regulation by SVs as a mechanism that may
contribute to the diverse levels of MaxiK channel surface expres-
sion (18). It was proposed that an ER retentionretrieval signal
embedded in the SV1 insert sequence significantly slows down the
normal trafficking of the constitutive MaxiK channel protein by
trapping it in the ER. The ER-restrained MaxiK channel would
create a large intracellular reservoir of MaxiK channels that upon
release can transiently increase the MaxiK channel surface expres-
sion. Further studies are necessary to determine whether CVLF can
be masked by other membrane or cytoplasmic proteins that could
lead to a transient release of MaxiK channels from the ER to the
cell surface.
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